ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is up 5% in pre-market trading after news that its drug Nuplazid received FDA approval on Friday after market …
Cowen’s healthcare analyst Eric Schmidt is weighing in with some thoughts on BIND Therapeutics (NASDAQ:BIND), as the company yesterday announced an upbeat strategic overview for 2015, along with …
